Industry News
HanAll Biopharma Secures Orphan Drug Designation in Japan for Batoclimab to Treat Thyroid Eye Disease

HanAll Biopharma has received Orphan Drug Designation (ODD) from the Ministry of Health, Labor and W...

read more
HanAll Biopharma Secures Orphan Drug Designation in Japan for Batoclimab to Treat Thyroid Eye Disease
March 19, 2025
Iantrek’s Bio-Interventional Technology Shows Positive Glaucoma Surgery Results

Iantrek Corporation has released promising results from its two-year clinical study on bio-reinforce...

read more
Iantrek’s Bio-Interventional Technology Shows Positive Glaucoma Surgery Results
March 19, 2025
China Approves First IGF-1R Monoclonal Antibody for Thyroid Eye Disease, Innovent Biologics Announces

China has approved SYCUME, the country’s first monoclonal antibody treatment for thyroid eye disease...

read more
China Approves First IGF-1R Monoclonal Antibody for Thyroid Eye Disease, Innovent Biologics Announces
March 18, 2025
Stealth BioTherapeutics Reaches 50% Enrollment in Phase 3 ReNEW Study for Dry AMD

Stealth BioTherapeutics Inc. has achieved 50% of its enrollment target in the global Phase 3 ReNEW s...

read more
Stealth BioTherapeutics Reaches 50% Enrollment in Phase 3 ReNEW Study for Dry AMD
March 18, 2025
Harrow Launches VEVYE Access For All, Reducing Patient Barriers for Dry Eye Disease Treatment

Harrow, a North American eyecare pharmaceuticals company, has introduced VEVYE Access For All, a new...

read more
Harrow Launches VEVYE Access For All, Reducing Patient Barriers for Dry Eye Disease Treatment
March 18, 2025
Study Reveals Most Glaucoma Patients Unaware of Preservative-Free Treatment Options

A nationwide survey conducted by the Preservative Freedom Coalition highlights a critical gap in pat...

read more
Study Reveals Most Glaucoma Patients Unaware of Preservative-Free Treatment Options
March 14, 2025
RadiusXR and Glaukos Collaborate with Topcon to Inspire Visual Field Solution Launch

Topcon Healthcare, RadiusXR, and Glaukos have announced a strategic collaboration to launch Inspire,...

read more
RadiusXR and Glaukos Collaborate with Topcon to Inspire Visual Field Solution Launch
March 14, 2025
Harrow Secures 5-Year Strategic Agreement for Triesence and Announces Next-Generation Development

Harrow has finalized a 5-year strategic supply and development (SSD) agreement to ensure the continu...

read more
Harrow Secures 5-Year Strategic Agreement for Triesence and Announces Next-Generation Development
March 13, 2025
Kodiak Sciences Completes Enrollment in Phase 3 GLOW2 Trial of Tarcocimab Tedromer for Diabetic Retinopathy

Kodiak Sciences has successfully completed patient enrollment for its Phase 3 GLOW2 trial, evaluatin...

read more
Kodiak Sciences Completes Enrollment in Phase 3 GLOW2 Trial of Tarcocimab Tedromer for Diabetic Retinopathy
March 12, 2025
More